Every year, 3.75 million or 9.2% of patients go on to long-term opioid use after a low-risk surgery (e.g. inguinal hernia repair, knee arthroscopy.)

80 Pills is the average number of opioid pills prescribed to patients after orthopedic surgery, whether they need them or not.

Of the 9.7 million people who misused pain relievers in 2019, 37.5% received the pills from a health care provider, and 50% obtained them from a friend.

80 percent of heroin users began by abusing prescription pain medications.

YOUth Positively Speaking about Actions to Avoid Opioid Addiction

Listen to the podcast to learn more about alternatives to opioids, safe medicine use and disposal and learn about national legislative efforts.

About the nopain act

The Non-Opioids Prevent Addiction in the Nation Act (“NOPAIN Act”) (S. 586/H.R. 3259) was reintroduced in Congress by Senators Shelley Moore Capito (R-WV), Jeanne Shaheen (D-NH), Rob Portman (R-OH), and Joe Manchin (D-WV) and Representatives Terri Sewell (D-AL), David McKinley (R-WV), Ann Kuster (D-NH), and Brian Fitzpatrick (R-PA). This bipartisan legislation is designed to increase utilization of non-opioid pain management approaches by addressing outdated federal reimbursement policies

This bill would ensure safe, non-addictive therapies are widely available to the tens of millions of Americans who undergo an outpatient surgical procedure every year.1 This policy change aims to reduce unnecessary exposure to opioids and the likelihood of opioid abuse or addiction following an acute pain incident.

Drug-related overdoses and deaths skyrocketed during the pandemic resulting in the highest rates ever recorded. Congress can act now to prevent addiction before it starts and ensuring those who need non-addictive pain therapies can access them. This bill would:

  • Expand patient and provider access to FDA approved non-opioid pain management approaches in all outpatient surgical settings for the next five years; and
  • Require a report to Congress on limitations, gaps, barriers to access, or deficits in Medicare coverage or reimbursement for therapeutic services.